Skip to main content

Advertisement

SpringerLink
Log in

From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome

  • Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Metabolic diseases are associated with chronic low-grade inflammation, which has been indicated as a potential mediator of endothelial dysfunction and cardiovascular disease. Visceral adiposity is thought to be the starting condition of the inflammatory state through the release of inflammatory cytokines, including TNF-alpha, CRP, and IL-6, which in turn promote endothelial dysfunction, endothelial expression of chemokines (IL-1) and adhesion molecules (ICAM-1, VCAM-1, and P-selectin), and the inhibition of anti-atherogenic factors (adiponectin). Obesity, metabolic diseases, and diabetes, all conditions characterized by abdominal fat, are well-recognized risk factors for sexual dysfunction in both sexes. Evidence from randomized-controlled trials supports the association between inflammatory milieau and erectile dysfunction in men suffering from metabolic diseases, whereas, in women, this has to be confirmed in further studies. A healthy lifestyle based on dietary pattern with high content of whole grain, fruit, nuts and seeds, and vegetables and low in sodium and saturated fatty acids plus regular physical activity may help to modulate the pro-inflammatory state associated with metabolic diseases and the related burden of sexual dysfunctions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874

    Article  CAS  Google Scholar 

  2. Esposito K, Giugliano D (2004) The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 14:228–232

    Article  CAS  Google Scholar 

  3. Esposito K, Giugliano F, Ciotola M, De Sio M, D’Armiento M, Giugliano D (2008) Obesity and sexual dysfunction, male and female. Int J Impot Res 20:358–365

    Article  CAS  Google Scholar 

  4. Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D (2005) Sexual dysfunction in women with the metabolic syndrome. Diabetes Care 28:756

    Article  Google Scholar 

  5. Esposito K, Giugliano F, Martedì E et al (2005) High proportions of erectile dysfunction in men with the metabolicsyndrome. Diabetes Care 28:1201–1203

    Article  Google Scholar 

  6. Maiorino MI, Bellastella G, Esposito K (2014) Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes 7:95–105

    PubMed  PubMed Central  Google Scholar 

  7. Kouidrat Y, Pizzol D, Cosco T et al (2017) High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 34:1185–1192

    Article  CAS  Google Scholar 

  8. Collaboration Emerging Risk Factors, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–140

    Article  Google Scholar 

  9. Ridker PM, Rifai N, Pfeffer M et al (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149–2153

    Article  CAS  Google Scholar 

  10. Ridker PM, Rifai N, Stampfer MJ et al (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772

    Article  CAS  Google Scholar 

  11. Blankemberg S, Tiret L, Bickel C et al (2002) Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:24–30

    Article  Google Scholar 

  12. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188

    Article  CAS  Google Scholar 

  13. Lindberg S, Jensen JS, Bjerre M et al (2015) Adiponectin, type 2 diabetes and cardiovascular risk. Eur J Prev Cardiol 22:276–283

    Article  Google Scholar 

  14. Pischon T, Girman CJ, Hotamisligil GS et al (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730–1737

    Article  CAS  Google Scholar 

  15. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 259:87–91

    Article  CAS  Google Scholar 

  16. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-alpha. J Clin Investig 94:1543–1549

    Article  CAS  Google Scholar 

  17. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135

    Article  CAS  Google Scholar 

  18. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745–E751

    Article  CAS  Google Scholar 

  19. Esposito K, Pontillo A, Ciotola M et al (2002) Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87:3864–3866

    Article  CAS  Google Scholar 

  20. Wang X, Bao W, Liu J et al (2013) Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 36:166–175

    Article  CAS  Google Scholar 

  21. Li S, Shin HJ, Ding EL, Van Dam RM (2009) Adiponectin levels and risk of type 2 Diabetes: a systematic review and meta-analysis. JAMA 302:179–188

    Article  CAS  Google Scholar 

  22. Fisman EZ, Motro M, Tenenbaum A (2003) Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2:11

    Article  Google Scholar 

  23. Esposito K, Nicoletti G, Giugliano D (2002) Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity. J Endocrinol Invest 25:646–649

    Article  CAS  Google Scholar 

  24. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 15 Dec 2017

  25. Health Effects Institute (2017) State of global air 2017. Special report. Health Effects Institute, Boston

    Google Scholar 

  26. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2003) Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139:161–168

    Article  Google Scholar 

  27. Ghalayini IF, Al-Ghazo MA, Al-Azab R et al (2010) Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men. Int J Impot Res 22:196–203

    Article  CAS  Google Scholar 

  28. Feldman HA, Johannes CB, Derby CA et al (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30:328–338

    Article  CAS  Google Scholar 

  29. Fung MM, Bettencourt R, Barrett-Connor E (2004) Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study. J Am Coll Cardiol 43:1405–1411

    Article  Google Scholar 

  30. Han TS, Tajar A, O’Neill TW et al (2011) Impaired quality of life and sexual function in overweight and obese men: the European male ageing study. Eur J Endocrinol 164:1003–1011

    Article  CAS  Google Scholar 

  31. Giugliano F, Esposito K, Di Palo C et al (2004) Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest 27:665–669

    Article  CAS  Google Scholar 

  32. Werner N, Nickenig G, Werner N et al (2007) Endothelial progenitor cells in health and atherosclerotic disease. Ann Med 39:82–90

    Article  CAS  Google Scholar 

  33. Werner N, Kosiol S, Schiegl T et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007

    Article  CAS  Google Scholar 

  34. Menegazzo L, Albiero M, Avogaro A, Fadini GP (2012) Endothelial progenitor cells in diabetes mellitus. BioFactors 38:194–202

    Article  CAS  Google Scholar 

  35. Burger D, Touyz RM (2012) Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 6:85–99

    Article  CAS  Google Scholar 

  36. Esposito K, Ciotola M, Maiorino MI et al (2009) Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. J Sex Med 6:107–114

    Article  Google Scholar 

  37. Patel DP, Craig JR Jr, Myers JB, Brant WO, Hotaling JM (2017) Serum biomarkers of erectile dysfunction in diabetes mellitus: a systematic review of current literature. Sex Med Rev 5:339–348

    Article  Google Scholar 

  38. Esposito K, Ciotola M, Giugliano F et al (2007) Association of body weight with sexual function in women. Int J Impot Res 19:353–357

    Article  CAS  Google Scholar 

  39. Kadioglu P, OzgilYetkin D, Sanli O et al (2010) Obesity might not be a risk factor for female sexual dysfunction. BJU Int 106:1357

    Article  Google Scholar 

  40. Maseroli E, Fanni E, Cipriani S et al (2016) Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med 13:1651–1661

    Article  Google Scholar 

  41. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645

    Article  CAS  Google Scholar 

  42. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ (2015) Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313:1973–1974

    Article  CAS  Google Scholar 

  43. Li J, Flammer AJ, Lennon RJ et al (2012) Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function. Mayo Clin Proc 87:968–975

    Article  Google Scholar 

  44. Corona G, Monami M, Rastrelli G et al (2011) Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 8:272–283

    Article  CAS  Google Scholar 

  45. Esposito K, Giugliano D (2011) Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther 90:169–173

    Article  CAS  Google Scholar 

  46. Besiroglu H, Otunctemur A, Ozbek E (2015) The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med 12:1309–1318

    Article  CAS  Google Scholar 

  47. Gautier A, Bonnet F, Dubois S et al (2013) Associations between visceral adipose tissue, inflammation and sex steroid concentrations in men. Clin Endocrinol 78:373–378

    Article  CAS  Google Scholar 

  48. Chrysohoou C, Panagiotakos D, Pitsavos C et al (2013) Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study. Rev Diabet Stud 10:27–38

    Article  Google Scholar 

  49. Bernini G, Versari D, Moretti A et al (2006) Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 91:1691–1697

    Article  CAS  Google Scholar 

  50. Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D (2005) The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 17:224–226

    Article  CAS  Google Scholar 

  51. Ponholzer A, Temml C, Rauchenwald M, Marszalek M, Madersbacher S (2008) Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? Int J Impot Res 20:100–104

    Article  CAS  Google Scholar 

  52. Martelli V, Valisella S, Moscatiello S et al (2012) Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. J Sex Med 9:434–441

    Article  CAS  Google Scholar 

  53. International Diabetes Federation. IDF diabetes atlas. Eighth edition. 2017

  54. McCabe MP, Sharlip ID, Lewis R et al (2016) Risk factors for sexual dysfunction among women and men: a consensus statement from the fourth International Consultation on Sexual Medicine 2015. J Sex Med 13:153–167

    Article  Google Scholar 

  55. Maiorino MI, Bellastella G, Della Volpe E et al (2017) Erectile dysfunction in young men with type 1 diabetes. Int J Impot Res 29:17–22

    Article  CAS  Google Scholar 

  56. Corona G, Giorda CB, Cucinotta D, Guida P, Nada E (2013) The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients. J Endocrinol Invest 36:864–868

    CAS  PubMed  Google Scholar 

  57. Araña Rosaínz Mde J, Ojeda MO, Acosta JR et al (2011) Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. J Sex Med 8:2017–2030

    Article  Google Scholar 

  58. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, Sildenafil Study Group (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397–1404

    Article  CAS  Google Scholar 

  59. Maiorino MI, Bellastella G, Esposito K (2015) Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl 17:5–10

    Article  Google Scholar 

  60. Esposito K, Ciotola M, Giugliano F et al (2007) Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 19:161–166

    Article  CAS  Google Scholar 

  61. Esposito K, Ciotola M, Giugliano F et al (2008) Phenotypic assessment of endothelial microparticles in diabetic and non diabetic men with erectile dysfunction. J Sex Med 5:1436–1442

    Article  Google Scholar 

  62. Maiorino MI, Bellastella G, Petrizzo M et al (2015) Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction. Endocrine 49:415–421

    Article  CAS  Google Scholar 

  63. Dandona P, Dhindsa S (2011) Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab 96:2643–2651

    Article  CAS  Google Scholar 

  64. Kapoor D, Clarke S, Channer KS, Jones TH (2007) Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl 30:500–507

    Article  CAS  Google Scholar 

  65. Dhindsa S, Ghanim H, Batra M et al (2016) Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes Care 39:82–91

    Article  Google Scholar 

  66. Miner M, Esposito K, Guay A, Montorsi P, Goldstein I (2012) Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med 9:641–651

    Article  Google Scholar 

  67. Pontiroli AE, Cortelazzi D, Morabito A (2013) Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 10:1044–1051

    Article  Google Scholar 

  68. Enzlin P, Rosen R, Wiegel M, DCCT/EDIC Research Group et al (2009) Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care 32:780–785

    Article  Google Scholar 

  69. Maiorino MI, Bellastella G, Castaldo F, Petrizzo M, Giugliano D, Esposito K (2017) Sexual function in young women with type 1 diabetes: the METRO study. J Endocrinol Invest 40:169–177

    Article  CAS  Google Scholar 

  70. Hotaling JM, Sarma AV, Patel DP, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group et al (2016) Cardiovascular autonomic neuropathy, sexual dysfunction, and urinary incontinence in women with type 1 diabetes. Diabetes Care 39:1587–1593

    Article  Google Scholar 

  71. Abu Ali RM, Al Hajeri RM, Khader YS, Shegem NS, Ajlouni KM (2008) Sexual dysfunction in Jordanian diabetic women. Diabetes Care 31:1580–1581

    Article  Google Scholar 

  72. Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D (2010) Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 22:179–184

    Article  CAS  Google Scholar 

  73. Musicki B, Liu T, Lagoda GA, Bivalacqua TJ, Strong TD, Burnett AL (2009) Endothelial nitric oxide synthase regulation in female genital tract structures. J Sex Med 3:247–253

    Article  Google Scholar 

  74. Comeglio P, Cellai I, Filippi S et al (2016) Differential effects of testosterone and estradiol on clitoral function: an experimental study in rats. J Sex Med 13:1858–1871

    Article  Google Scholar 

  75. Jannini EA (2017) SM= SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex Med Rev 5:349–364

    Article  Google Scholar 

  76. Meldrum DR, Gambone JC, Morris MA, Meldrum DA, Esposito K, Ignarro LJ (2011) The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 108:599–606

    Article  Google Scholar 

  77. Hackett G, Krychman M, Baldwin D et al (2016) Coronary heart disease, diabetes, and sexuality in men. J Sex Med 13:887–904

    Article  Google Scholar 

  78. Gazzaruso C, Solerte SB, Pujia A et al (2008) Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 51:2040–2044

    Article  Google Scholar 

  79. World Health Organization (2017) World health statistics 2017: monitoring health for the SDGs, sustainable development goals. World Health Organization, Geneva

    Google Scholar 

  80. Esposito K, Giugliano D (2006) Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 27:15–20

    Article  Google Scholar 

  81. Calder PC, Ahluwalia N, Brouns F et al (2011) Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 106:S5–S78

    Article  CAS  Google Scholar 

  82. Giugliano D, Ceriello A, Esposito K (2006) The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48:677–685

    Article  CAS  Google Scholar 

  83. Esposito K, Pontillo A, Di Palo C et al (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799–1804

    Article  CAS  Google Scholar 

  84. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440–1446

    Article  CAS  Google Scholar 

  85. Esposito K, Giugliano F, Di Palo C et al (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978–2984

    Article  CAS  Google Scholar 

  86. Maiorino MI, Bellastella G, Petrizzo M, Scappaticcio L, Giugliano D, Esposito K (2016) Anti-inflammatory effect of Mediterranean diet in type 2 diabetes is durable: 8-year follow-up of a controlled trial. Diabetes Care 39:e44–e45

    Article  Google Scholar 

  87. Maiorino MI, Bellastella G, Petrizzo M, Scappaticcio L, Giugliano D, Esposito K (2016) Mediterranean diet cools down the inflammatory milieu in type 2 diabetes: the MÉDITA randomized controlled trial. Endocrine 54:634–641

    Article  CAS  Google Scholar 

  88. Estruch R, Ros E, Salas-Salvadó J et al (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368:1279–1290

    Article  CAS  Google Scholar 

  89. Khera AV, Emdin CA, Drake I et al (2016) Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med 375:2349–2358

    Article  CAS  Google Scholar 

  90. Esposito K, Giugliano F, Maiorino MI, Giugliano D (2010) Dietary factors, Mediterranean diet and erectile dysfunction. J Sex Med 7:2338–2345

    Article  Google Scholar 

  91. Giugliano F, Maiorino MI, Di Palo C et al (2010) Adherence to Mediterranean diet and sexual function in women with type 2 diabetes. J Sex Med 7:1883–1890

    Article  Google Scholar 

  92. Esposito K, Ciotola M, Giugliano F et al (2009) Effects of intensive lifestyle changes on erectile dysfunction in men. J Sex Med 6:243–250

    Article  CAS  Google Scholar 

  93. Esposito K, Ciotola M, Giugliano F et al (2007) Mediterranean diet improbe sexual function in women with the metabolic syndrome. Int J Impot Res 19:486–491

    Article  CAS  Google Scholar 

  94. Esposito K, Ciotola M, Giugliano F et al (2006) Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 18:405–410

    Article  CAS  Google Scholar 

  95. Maiorino MI, Bellastella G, Chiodini P et al (2016) Primary Prevention of Sexual Dysfunction With Mediterranean Diet in Type 2 Diabetes: the MÈDITA Randomized Trial. Diabetes Care 39:e143–e144

    Article  Google Scholar 

  96. Maiorino MI, Bellastella G, Caputo M et al (2016) Effects of Mediterranean diet on sexual function in people with newly diagnosed type 2 diabetes: the MÈDITA trial. J Diabetes Complications 30:1519–1524

    Article  Google Scholar 

  97. Wing RR, Bond DS, Gendrano IN et al (2013) Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care 36:2937–2944

    Article  Google Scholar 

  98. Wing RR, Rosen RC, Fava JL et al (2010) Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med 7:156–165

    Article  Google Scholar 

  99. Maiorino MI, Bellastella G, Esposito K (2017) Sexual dysfunctions in diabetes: a gender issue. J Diabetes Complications 31:785–786

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolic Diseases, Department of Medical, Surgical, Neurological Metabolic Sciences and Aging, University of Campania “Luigi Vanvitelli”, Piazza L. Miraglia n° 2, 80138, Naples, Italy

    M. I. Maiorino, G. Bellastella & D. Giugliano

  2. Diabetes Unit, Department of Medical, Surgical, Neurological Metabolic Sciences and Aging, University of Campania “Luigi Vanvitelli”, Piazza L. Miraglia n° 2, 80138, Naples, Italy

    K. Esposito

Authors
  1. M. I. Maiorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Bellastella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Esposito.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This manuscript is a review of the literature and does not contain original research either on animal or on human subjects.

Informed consent

For this type of study, informed consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maiorino, M.I., Bellastella, G., Giugliano, D. et al. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest 41, 1249–1258 (2018). https://doi.org/10.1007/s40618-018-0872-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0872-6

Keywords

Search

Navigation